Please login to the form below

medicines optimisation

This page shows the latest medicines optimisation news and features for those working in and with pharma, biotech and healthcare.

ABPI and AHSN Network targets NHS biomedical innovations uptake

The UK pharma industry association the ABPI has announced a five-year deal with the AHSN Network aimed at encouraging a quicker, more consistent stream of innovative medicines into the NHS. ... These areas include economic growth, digital and artificial

Latest news

Daily Brief: Theresa May and the diabetes sensor, Biosimilars hit Roche in Europe, Gilead CEO to step down

Strong launches for new medicines Ocrevus, Tecentriq and Alecensa, especially in Germany, partially offset the loss in Europe. ... The device has not been formally reviewed by NICE, but by England’s new network of Regional Medicines Optimisation
NHS seeks 'solution creators' from within pharma

There has also been “a degree of convergence”among the people and bodies that work on assessing new medicines, he added, whether they be involved with NICE, the Cancer Drugs Fund ... However, a warning note about partnership working was sounded by
Pharma could make more of its real world evidence

But pharmaceutical companies do – and they are perfectly placed to help the NHS improve medicines optimisation. ... In reality, many pharma companies have adapted their operations to develop processes and strategies to collect RWE for their medicines.
Industry pays £310m to underwrite medicines bills

Industry agreed to the PPRS in order to improve the use of innovative medicines in the UK. ... We are working with the Department of Health, NHS England and government to ensure action in key areas such as changes to NICE's decision making framework and
Patients should have a say in their medication, claims NICE

Paul Chrisp, programme director for the medicines and prescribing centre at NICE, said: “ The NICE guideline on medicines optimisation sets out what needs to be done by all health and social ... Medicines optimisation is not a new concept. “ This

More from news
Approximately 11 fully matching, plus 19 partially matching documents found.

Latest Intelligence

Immuno-oncology is fundamentally changing what value means, but how quickly can the pharma marketing, educational and service model change to reflect that?

In recent years, biosimilars (highly similar copies of biologic medicines) have taken large shares of many markets. ... Considerable effort was directed towards medicines optimisation and building an evidence base for the wider use of NOACs in
How AbbVie Care is putting patients at the centre

Industry must assume a responsibility to move beyond just the manufacture of medicines. ... Create a reliable supply chain ensuring that patients get the right medicine at the right time, supporting medicines optimisation.
It's time to get diabetes right

All with negative implications for patients - but to date focusing on specialist medicines. ... It is clear that the medicines optimisation agenda is of more importance now than ever.
Communicating value

In England the NHS-driven Medicines Optimisation programme will this year engage local payers and providers on the ability of good medicines usage to improve patient adherence and outcomes and reduce ... But marketers need to find differentiators for

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

ABPI names NHS partnership manager

In his new role, he will manage the four ABPI regional partnership managers and lead ABPI activities in academic health science networks and medicines optimisation. ... ensure appropriate medicines and technologies are available to all eligible

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

Sir Bruce Keogh is appointed chair of judges for HSJ Awards

The eight new awards include acute or specialist services redesign, patient digital participation, creating a supportive staff culture and optimisation of medicines management.
How will the NHS’s new medicines savings drive affect pharma?

The CCGs will be monitored by four Regional Medicines Optimisation Committees(RMOCs) which were launched recently to avoid duplication when evaluating medicines, particularly those which are not evaluated by NICE. ... Thanks to powerful data analytics

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Account Director: Negotiable

Account Manager, Healthcare Communications: £32, 000 - £40, 000 benefits

Medical Strategic Director, Healthcare Advertising Agency: Salary TBC

Editorial Director – Medical Education: Neg

Account Director – Global Healthcare PR: Salary TBC

Account Manager- Manchester, Macclesfield or Glasgow: Negotiable

Senior Account Manager - Med Comms: Highly Competitive Salary &Benefits

Healthcare PR Director: £100, 000 – £120, 000 benefits

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Associate Medical Director: Salary TBC

Project / Account Manager (Medical Education): Salary TBC

Healthcare Advertising Account Manager / Senior AM / AD: Salary TBC

Associate Medical Director: Highly Competitive

Account Director - Award Winning Healthcare Advertising Agency -...: £50000 - £68000

Senior/ Market Access Consultant, UK, HOME BASED, £50-60K: Excellent package

SENIOR MEDICAL WRITER IN ONCOLOGY: Up to £60, 000.00 pension bonus

Scientific Team Lead: Competitive Salary

Account Director - Digital: Great salary and benefits

Senior Account Manager / Account Director - Med Comms: Great salary and benefits

Experienced Editor, London, Medical Communications: Competitive package

Director – Head of Public Affairs: Neg

Lead Medical Copywriter, Healthcare Brand Communications, London: Excellent package

Senior Account Executive – Medical Communications: Salary TBC

Director Healthcare PR Communications: Salary TBC

Account Manager, Healthcare Advertising: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Making Europe a leader in bioscience: boosting trust and opening minds: A vision of Paris as Europe’s leading hub for life sciences innovation...
Tackling a formidable foe: Ali Frederic Ben-Amor tells how Merck is taking the fight to multiple sclerosis...
Cancer care – the power of new technologies: With patient numbers set to soar, how can we make a difference?...